Your browser doesn't support javascript.
loading
Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Phase I/II, Open-Label, Multicenter Study.
Li, Jian; Zhang, Xinhua; Deng, Yanhong; Wu, Xin; Zheng, Zhichao; Zhou, Yongjian; Cai, Shirong; Zhang, Yanqiao; Zhang, Jun; Tao, Kaixiong; Cui, Yuehong; Cao, Hui; Shen, Kuntang; Yu, Jiren; Zhou, Ye; Ren, Wenxiao; Qu, Chenglin; Zhao, Wanqi; Hu, Jin; Wang, Wei; Yang, Jason; Shen, Lin.
Afiliação
  • Li J; Department of Gastrointestinal Oncology, Laboratory of Carcinogenesis and Translational Research of the Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, People's Republic of China.
  • Zhang X; Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Deng Y; Department of Medical Oncology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Wu X; Department of General Surgery, Chinese PLA General Hospital, Beijing, People's Republic of China.
  • Zheng Z; Department of Gastrosurgery, Liaoning Cancer Hospital & Institute, Shenyang, People's Republic of China.
  • Zhou Y; Department of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
  • Cai S; Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Zhang Y; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.
  • Zhang J; Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
  • Tao K; Department of Gastroenterology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Cui Y; Department of Medical Oncology, Fudan University Zhongshan Hospital, Shanghai, People's Republic of China.
  • Cao H; Department of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
  • Shen K; Department of General Surgery, Fudan University Zhongshan Hospital, Shanghai, People's Republic of China.
  • Yu J; Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University, Hangzhou, People's Republic of China.
  • Zhou Y; Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Ren W; CStone Pharmaceuticals (Suzhou), Suzhou, People's Republic of China.
  • Qu C; CStone Pharmaceuticals (Suzhou), Suzhou, People's Republic of China.
  • Zhao W; CStone Pharmaceuticals (Suzhou), Suzhou, People's Republic of China.
  • Hu J; CStone Pharmaceuticals (Suzhou), Suzhou, People's Republic of China.
  • Wang W; CStone Pharmaceuticals (Suzhou), Suzhou, People's Republic of China.
  • Yang J; CStone Pharmaceuticals (Suzhou), Suzhou, People's Republic of China.
  • Shen L; Department of Gastrointestinal Oncology, Laboratory of Carcinogenesis and Translational Research of the Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, People's Republic of China.
Oncologist ; 28(2): 187-e114, 2023 02 08.
Article em En | MEDLINE | ID: mdl-36477870
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumores do Estroma Gastrointestinal / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumores do Estroma Gastrointestinal / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article